**Core Concept**
In porphyria patients, certain anesthetic agents can exacerbate the disease by inducing the cytochrome P450 system, leading to increased production of toxic heme precursors. The safest anesthetic agent should minimize this risk.

**Why the Correct Answer is Right**
The correct answer is **Desflurane**. Desflurane is a volatile anesthetic that undergoes minimal metabolism by the liver, reducing the risk of inducing the cytochrome P450 system and subsequent heme precursor production. This makes it a safer choice for patients with porphyria. In contrast, other anesthetic agents like barbiturates, etomidate, and propofol are more likely to induce the cytochrome P450 system, increasing the risk of exacerbating porphyria.

**Why Each Wrong Option is Incorrect**
**Option A:** **Barbiturates** are incorrect because they are known to induce the cytochrome P450 system, increasing the production of toxic heme precursors in porphyria patients. This can lead to acute attacks and worsening of the disease.

**Option B:** **Etomidate** is incorrect because it is also a substrate for the cytochrome P450 system, which can lead to increased production of toxic heme precursors in porphyria patients.

**Option C:** **Propofol** is incorrect because it is a substrate for the cytochrome P450 system and can induce the production of toxic heme precursors in porphyria patients.

**Clinical Pearl / High-Yield Fact**
When managing a patient with porphyria, it's essential to choose an anesthetic agent that minimizes the risk of exacerbating the disease. Remember that volatile anesthetics like desflurane, which undergo minimal metabolism, are safer choices.

**Correct Answer:** C. Desflurane.